POLITANO, Luisa
 Distribuzione geografica
Continente #
NA - Nord America 6.642
EU - Europa 6.252
AS - Asia 1.180
SA - Sud America 14
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.118
Nazione #
US - Stati Uniti d'America 6.607
IE - Irlanda 2.038
UA - Ucraina 1.062
GB - Regno Unito 845
IT - Italia 531
DE - Germania 522
SG - Singapore 436
CN - Cina 371
FR - Francia 341
SE - Svezia 314
FI - Finlandia 282
TR - Turchia 213
GR - Grecia 177
VN - Vietnam 75
BE - Belgio 37
CA - Canada 30
ES - Italia 25
HK - Hong Kong 25
IN - India 19
CZ - Repubblica Ceca 17
AT - Austria 15
KR - Corea 12
NL - Olanda 9
EU - Europa 8
ID - Indonesia 8
BR - Brasile 7
EG - Egitto 6
PT - Portogallo 6
MX - Messico 5
NZ - Nuova Zelanda 5
RU - Federazione Russa 5
AU - Australia 4
CH - Svizzera 4
CY - Cipro 4
IS - Islanda 4
JP - Giappone 4
RO - Romania 4
SC - Seychelles 4
CL - Cile 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DK - Danimarca 2
HR - Croazia 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SM - San Marino 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 14.118
Città #
Dublin 2.036
Jacksonville 1.647
Chandler 1.008
Santa Clara 871
Princeton 316
Singapore 282
Medford 248
Roxbury 195
Ann Arbor 183
Boardman 180
Wilmington 148
San Mateo 128
Woodbridge 125
Bremen 111
Cambridge 90
Caserta 90
Beijing 81
Dong Ket 66
Des Moines 58
Mountain View 52
Düsseldorf 42
Houston 37
Jinan 34
New York 33
Brussels 28
Ashburn 25
Nanjing 24
Norwalk 24
Auburn Hills 23
Redwood City 22
Hong Kong 21
Munich 20
Helsinki 19
Nanchang 18
Rome 18
Hebei 17
Shenyang 16
Los Angeles 15
Vienna 15
Hangzhou 14
Naples 14
Napoli 14
Haikou 13
Milan 13
Santiago de Compostela 13
Guangzhou 12
West Jordan 12
Zhengzhou 12
Ottawa 11
Seoul 11
Taiyuan 11
Tianjin 11
Venice 11
London 10
Taizhou 10
Brno 9
Jiaxing 9
Trieste 9
Changsha 8
Lanzhou 7
Lappeenranta 7
Ningbo 7
Seattle 7
Barano D'ischia 6
Columbus 6
Grafing 6
Ho Chi Minh City 6
Olomouc 6
Shanghai 6
Toronto 6
Avellino 5
Castellammare Di Stabia 5
Frankfurt am Main 5
Halle 5
Pune 5
Tappahannock 5
Venezia 5
Antalya 4
Cedar Knolls 4
Groningen 4
Kocaeli 4
Lubbock 4
Madrid 4
Palermo 4
Paterno 4
Québec 4
San Mango 4
Agropoli 3
Andover 3
Aversa 3
Bengaluru 3
Bolzano 3
Brescia 3
Castelfidardo 3
Changchun 3
Dearborn 3
Ferrara 3
Gunzenhausen 3
Hanoi 3
Kunming 3
Totale 8.777
Nome #
1) Comparison between SPECT myocardical scintigraphy with 201Tl and 99mTc-MIBI in patients affected by Duchenne's dystrophy 148
1) Study of myocardial perfusion with Tl-201 in patients affected by Duchenne's/Becker's muscolar dystrophy 142
IperCKemia asintomatica. Quando e perchè fare l'indagine genetica 118
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 88
Cardiomyopathies associated with Muscular Dystrophies 86
Novel small mutations along the DMD/BMD gene associated with different phenotypes 83
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 77
High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm 76
A report on 528 intragenic deletions detected in DMD and BMD patients by an Italian collaborative study 76
Novel mutations in LMNA A/C gene and associated phenotypes 75
Dispositivo per la valutazione del test del cammino dei 6 minuti 74
Dispositivo per la valutazione del test del "cammino dei sei minuti (six minutes walking test)" 73
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 72
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 71
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 71
Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life. 71
Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene 71
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 70
Burden, professional support, and social network in families of children and young adults with muscular dystrophies. 69
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 69
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 68
SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function 68
Multiple heterozygosity for different muscle genes is not rare among individuals with pauci-symptomatic hyperCKemia 68
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 67
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein 67
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies 67
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 67
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 66
Identification of the Syrian hamster cardiomyopathy gene 66
Le Distrofie dei Cingoli autosomiche recessive: calpainopatie e disferlinopatie 65
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies 65
A Unique Myopathy Syndrome in a Patient Disclosing Clinical, Laboratory, and Genetic Findings of Late-Onset Pompe Disease, Together with a Lack of Dysferlin on Muscle Biopsy 65
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 64
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 64
"I have got something positive out of this situation": psychological benefits of caregiving in relatives of young people with muscular dystrophy. 63
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 63
Dystrophin gene scanning by DHPLC of DMD carriers without deletions or duplications 63
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy 62
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 62
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 62
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 62
6 Min walk test 12 month changes in DMD: correlation with the genotype 62
X-linked Emery-Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample 61
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 61
Struggle for life in lethal muscular diseases ultimate achievement 61
Unusual association of Kallmann syndrome with empty sella and arachnoid cyst 60
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 60
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes 60
Evaluation of the cardiomyopathy in Becker muscular dystrophy 60
X chromosome inactivation pattern in Duchenne muscular dystrophy carriers 60
Miocardiopatie e miopatie infiammatorie. 60
The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients. 60
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 59
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 59
Corneal endothelium study in patients with myotonic distrophy. 59
Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy 59
Molecular and Muscle Pathology in a series of Caveolinopathy patients 58
Acta Myologica (myopathies, cardiomyopathies and neuromyopathies) 58
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 58
Dysferlinopathy presenting as facio-scapulo-humeral dystrophy 58
Double carrier status in CANP3 and beta-sarcoglycan genes results in a mild disease phenotype 58
Next generation sequencing applications are ready for genetic diagnosis of muscular dystrophies. 58
Oral presentation: Treatment of Duchenne dystrophy: results of 7 years cloprednol oral administration 58
Successful combined prenatal diagnosis for Duchenne and facio-scapulo- humeral dystrophies 57
Evaluation of Becker cardiomyopathy by Vest investigation 57
24 month longitudinal data in ambulant boys with D uchenne muscular dystrophy. 57
Anterior capsule phimosis and capsular block syndrome in a patient with Steinert myotonic dystrophy: A case report 57
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 57
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 57
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 57
Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series 57
Detection of a nonsense mutation in the dystrophin gene by multiple SSCP 56
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 56
Gene redundancies in the dystrophin-associated protein complex 56
Advances in basic and clinical research in laminopathies. 56
G.O.7 Multiple genetic variations in limb-girdle muscular dystrophies 56
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 56
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 55
Clinical and genetic findings in sarcoglycanopathies 55
Analysis of caveolin-3 (CAV-3) gene in patients with limb-girdle muscular dystrophies and/or isolated hyperCKemia 55
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 55
Growth hormone improves left ventricular loading conditions in Becker Muscular Dystrophy 55
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 54
A novel homozygous beta-sarcoglycan gene mutation: case description. 54
The QT dispersion in the risk stratification of sudden death in Becker patients 54
Il trattamento chirurgico delle scoliosi nella Distrofia Muscolare di Duchenne. 54
DNA and tissue bank: Activities and perspectives in Naples 54
Assessment of Upper Limb function in DMD patients: Comparison with normative data 54
Aspetti clinici, genetici ed epidemiologici delleDistrofie muscolari dei Cingoli nel Sud Italia 53
Prevalence of congenital muscular dystrophy in Italy: A population study. 52
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 52
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 52
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 52
42nd ENMC Sponsored International Workshop: X-linked Cardiomyopathies 52
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 52
Arrhythmic risk in Steinert Disease 52
Le conseil genetique dans les dystrophies musculaires: resultats de 10 ans d'approche moleculaire 52
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys. 51
Structural basis of cardiomyopathy in Duchenne/Becker carriers. Endomyocardial biopsy evaluation 51
Une forme méconnue de myopathie. III. Definition et caractères cliniques 51
Totale 6.364
Categoria #
all - tutte 65.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020718 0 0 0 0 0 47 348 43 128 62 60 30
2020/20212.350 213 5 284 171 397 11 308 272 14 308 230 137
2021/20221.919 138 14 32 44 701 11 22 50 57 159 143 548
2022/20233.815 366 98 25 318 390 296 21 214 1.893 26 77 91
2023/20241.332 114 59 60 128 526 51 13 25 8 20 90 238
2024/20251.217 21 24 44 93 606 429 0 0 0 0 0 0
Totale 14.520